Cosmetics: MoCRA Registration, Listing and Safety Responsibilities

Manufacturers and processors assess facility-registration obligations; the responsible person is generally the manufacturer, packer or distributor named on the label. Product listing is the responsible person’s duty. These roles can sit with different entities, so supplier and brand-owner arrangements need clear information exchange rather than assuming one registration covers the entire commercial chain. FDA registration explanation.

Covered facilities register and renew every two years, while responsible persons list marketed cosmetic products and provide annual updates. The submitted information includes the required facility or product details and ingredient information. FDA supplies electronic submission options and forms. Maintain a controlled submission record so changes in product composition or facility information can be assessed. FDA submission resources.

MoCRA requires the responsible person to ensure and maintain records supporting adequate safety substantiation. Serious adverse events also trigger reporting and record responsibilities. Safety substantiation depends on relevant, scientifically robust evidence; neither a registration entry nor an ingredient inventory demonstrates that the finished product is safe under its actual conditions of use. FDA MoCRA explanation.

Certain small businesses are exempt from specified GMP, registration and listing requirements. The exemptions do not extend to all products, including the special categories described by FDA, and do not erase every cosmetics obligation. Certain drug- and device-related circumstances also receive specific treatment. Record the actual exemption basis rather than using a general small-business label. MoCRA exemptions.

FDA’s December 2024 registration guidance is final, but its page identifies Appendix B questions 20–22 as distributed for comment. MoCRA also directs additional rulemaking. FDA’s overview identifies the December 2024 talc-asbestos testing proposal and its November 2025 withdrawal; that proposal is not a current final testing mandate. Guidance status · MoCRA implementation.

FDA states that it does not issue certificates verifying cosmetic registration, listing or exemption. Identify the regulated roles, resolve coverage, assemble submission data and retain the submission history. Evaluate safety and adverse-event systems separately. Commercial material must not describe a registration or listing number as FDA approval, product certification or agency endorsement. FDA important notes.